NCT00821002View on ClinicalTrials.gov

A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

Latanoprost

Comparison of punctal plug placement between upper and lower puncta

Trial Locations (1)

94025

Menlo Park

Sponsors
All Listed Sponsors
collaborator

QLT Inc.

INDUSTRY

lead

Mati Therapeutics Inc.

INDUSTRY

NCT00821002 - A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS) | Biotech Hunter | Biotech Hunter